Oncotarget

Vol 10, No 62

November 19, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 62 of Oncotarget features Figure 7, "Proposed model of the hyperploid pathway as a salvage survival strategy regulated by the G2-M checkpoint," by Yeung, et al.

Table of Contents

Research Papers

Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget’s disease

Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget’s disease

https://doi.org/10.18632/oncotarget.27272

Thierry M. Nordmann, Olivia Messerli-Odermatt, Larissa Meier, Sara Micaletto, Thomas Coppetti, Mirjam Nägeli, Jivko Kamarachev, Ken Kudura, Sandra N. Freiberger, Tamara Rordorf, Joanna Mangana, Ralph Braun,  and Reinhard Dummer
6647-6650
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth

A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth

https://doi.org/10.18632/oncotarget.27286

Sylvie Carmona, Jean-Michel Brunel, Rénaté Bonier, Véronique Sbarra, Stéphane Robert, Patrick Borentain, Dominique Lombardo, Eric Mas,  and René Gerolami
6651-6667
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion

Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion

https://doi.org/10.18632/oncotarget.27313

Bharat Joshi, Judy Pawling, Jay Shankar, Karina Pacholczyk, Yohan Kim, Wynn Tran, Fanrui Meng, Anas M. Abdel Rahman, Leonard J. Foster, Hon S. Leong, James W. Dennis,  and Ivan R. Nabi
6668-6677
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade

Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade

https://doi.org/10.18632/oncotarget.27320

Sheila Dakhel, Tiziano Ongaro, Baptiste Gouyou, Mattia Matasci, Alessandra Villa, Dario Neri,  and Samuele Cazzamalli
6678-6690
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models

Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models

https://doi.org/10.18632/oncotarget.27330

Tony Yeung, Oliver Fung, Mikhail Bashkurov, Arian Khandani, Omar Subedar, Alexandra Wudwud, Patricia Shaw, Blaise Clarke, John Bartlett, Robert Rottapel,  and Andras Kapus
6691-6712
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study

Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study

https://doi.org/10.18632/oncotarget.27333

Andro Košec, Ruđer Novak, Paško Konjevoda, Vladimir Trkulja, Vladimir Bedeković,  and Lovorka Grgurević
6713-6722
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

https://doi.org/10.18632/oncotarget.27336

Anne-Julie Cloux, Dominique Aubry, Mathieu Heulot, Christian Widmann, Oussama ElMokh, Francesco Piacente, Michele Cea, Alessio Nencioni, Axel Bellotti, Karima Bouzourène, Maxime Pellegrin, Lucia Mazzolai, Michel A. Duchosal,  and Aimable Nahimana
6723-6738
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Reviews

The impact of systemic precision medicine and immunotherapy treatments on brain metastases

The impact of systemic precision medicine and immunotherapy treatments on brain metastases

https://doi.org/10.18632/oncotarget.27328

Rowland H. Han, Gavin P. Dunn, Milan G. Chheda,  and Albert H. Kim
6739-6753
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Retraction

Retraction: Relationship between rs1801157 polymorphism in stromal cell-derived factor gene and systemic lupus erythematosus risk

Retraction: Relationship between rs1801157 polymorphism in stromal cell-derived factor gene and systemic lupus erythematosus risk

https://doi.org/10.18632/oncotarget.27351

Can Qian, Qinghua Zou,  and Yong Wang
6754-6754
Retraction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC